Details

Population frequencies of thiopurine-related pharmacogenes in healthy individuals from Kosovo
ID Pasha, Flaka (Author), ID Urbančič, Dunja (Author), ID Gosheva, Gordana (Author), ID Zhubi, Bukurije (Author), ID Qormemeti, Safete Maliqi (Author), ID Krasniqi, Shaip (Author), ID Mlinarič-Raščan, Irena (Author)

.pdfPDF - Presentation file, Download (546,43 KB)
MD5: FF44C100909DA2E765C590B7F61DEC08
URLURL - Source URL, Visit https://www.nature.com/articles/s41439-026-00337-3 This link opens in a new window

Abstract
Personalized thiopurine therapy is among the most established examples of pharmacogenomics translated into clinical practice. Variants in TPMT (rs1800462, rs1800460, rs1142345) and NUDT15 (rs116855232) are recognized clinical predictors of thiopurine efficacy and toxicity. Additional variants in genes such as PACSIN2 (rs2413739), ITPA (rs1127354) and MTHFR (rs1801133 and rs1801131), also contribute to variability in drug response. Here we characterize the frequency of the pharmacogenetic variants involved in thiopurine metabolism in a healthy population of Kosovo. We genotyped 299 healthy blood donors for polymorphisms. Among TPMT variant alleles, TPMT*3A was observed at a frequency of 2.0%, and the TPMT*3C at 0.1%. Notably, the MTHFR 677T variant (rs1801133) was significantly more frequent in the Kosovo population (49.8%) compared with the global and European frequencies. The minor allele frequency of MTHFR rs1801131 was 27.4%. Minor allele frequencies for PACSIN2 rs2413739 and ITPA rs1127354 variants were 48.8% and 4.0%, respectively. Sequencing of NUDT15 revealed six variants, with rs116855232 present at frequency of 0.8%. These findings provide important insights into the pharmacogenomic profile of the Kosovo population and support the implementation of pre-emptive genotyping to improve the safety and efficacy of thiopurine therapy in the region.

Language:English
Keywords:genetics research, pharmacogenomics
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2026
Number of pages:Str. 1-7
Numbering:Vol. 13, iss. 1, art. 3
PID:20.500.12556/RUL-180570 This link opens in a new window
UDC:615.015:575.111
ISSN on article:2054-345X
DOI:10.1038/s41439-026-00337-3 This link opens in a new window
COBISS.SI-ID:271195139 This link opens in a new window
Publication date in RUL:11.03.2026
Views:180
Downloads:92
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Human genome variation
Shortened title:Hum. genome var.
Publisher:Nature Publishing Group
ISSN:2054-345X
COBISS.SI-ID:523116057 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:genetske preiskave, farmakogenomika

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:I0-0022
Name:Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL)

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:I0-E011
Name:EATRIS

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back